The 30th Annual Meeting of the Japanese Society for Vaccinology/The 67th Annual Meeting of the Japanese Society of Clinical Virology

*Kousuke Utsunomiya^1,2, Toshiro Hirai^1,2,3,4, Yasuo Yoshioka^1,2,3,4,5 (1. School of Pharmaceutical Sciences, The University of Osaka, 2. Research Institute for Microbial Diseases, The University of Osaka, 3. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 4. Center for Advanced Modalities and DDS, The University of Osaka, 5. The Research Foundation for Microbial Diseases of Osaka University)

*Kotaro Taniguchi^1,2, Yuta Kunishima^2,3, Kota Senpuku^1,2, Toshiro Hirai^1,2,4,5, Taiki Ito^2,4,5, Yasuo Yoshioka^1,2,3,4,5 (1. Laboratory of Nano-design for Innovate Drug Development, Graduate School of Pharmaceutical Sciences, The University of Osaka, 2. Vaccine Creation Group,Research Institute for Microbial Diseases, The University of Osaka, 3. The Research Foundation for Microbial Diseases of Osaka University, 4. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 5. Center for Advanced Modalities and DDS, The University of Osaka)

*Sayuri Nakahara¹, Takayuki Matsumura², Kazutaka Terahara², Daiki Oka¹, Tomohiro Takano², Saya Moriyama^2,3, Masanori Isogawa², Yoshimasa Takahashi² (1. Meiji Seika Pharma Co.,Ltd., 2. Japan Institute for Health Security, 3. Center for infectious disease education and research)

*Aikeda AISHAJIANG¹, Yuki Kitai¹, Miyuki Kawase², Kazuya Shirato², Shohei Kojima³, Yuri Furusawa⁴, Yukiko Akahori¹, Hiroshi Katoh¹, Hidekazu Nishimura⁵, Yoshihiro Kawaoka⁶, Makoto Takeda¹ (1. Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 2. National Institute of Infectious Diseases, Japan Institute for Health Security, 3. WPI-Bio2Q, Keio University, 4. RIKEN Center for Integrative Medical Sciences, 5. Virus Research Center, Clinical Research Division, Sendai Medical Center, 6. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center)

*Yuya Fukuda Fukuda¹, Yoshiki Fujii², Yoshimasa Kudou¹, Shuhei Adachi¹, Toru Higuchi¹, Noritaka Shintani¹, Atsuo Togashi¹, Satoshi Hirakawa¹, Takeshi Tsugawa¹ (1. Department of Pediatrics, Sapporo Medical University School of Medicine, 2. Department of Virology II, National Institute of Infectious Diseases, Japan Institute for Health Security)

*Haruna Nishijima¹, Kanako Watanabe¹, Keiko Taya², Naruhiko Ishiwada³, Tomoko Ogawa⁴, Masahiro Fujii⁵, Shinichi Sato⁶ (1. School of Health Sciences, Faculty of Medicine, Niigata University, 2. Kanagawa Prefectural Institute of Public Health, 3. Chiba University, 4. Graduate School of Medicine Infectious Disease Pathobiology, Chiba University, 5. Niigata University, 6. Abikoseijinkai Hospital)

*Shinya Sato¹, Yuta Aizawa¹, Jun Tachikawa¹, Yuko Suzuki¹, Rie Habuka¹, Kanako Watanabe², Kazufumi Haino³, Koji Nishijima³, Akihiko Saitoh¹ (1. Department of Pediatrics, Niigata University Graduate School of Medical, Dentistry and Health Sciences, 2. Department of Medical Technology, Niigata University Graduate School of Medical, Dentistry and Health Sciences, 3. Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical, Dentistry and Health Sciences)